Pilar Navarro

ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 18

Top Venues

Nature communications

Cancers

Cells

Proceedings of the National Academy of Sciences of the United States of America

CSIC- Institute of Biomedical Research of Barcelona (IIBB)

Instituto de Investigaciones Biomédicas Alberto Sols (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

CSIC- Institute of Biomedical Research of Barcelona (IIBB) Mar 16 2017

Spain

Cientifico Titular

IMIM-Hospital del Mar Medical Research Institute Mar 29 1999

Spain

Head of the group: "Galectins and gene expression control in cancer" :: Cancer Research Programme

Education History

Instituto de Investigaciones Biomédicas Alberto Sols Jan 01 1989 - Dec 31 1992

Spain

PHD :: Bioquímica y Biología Celular

Publications

Jenniffer Linares, Anna Sallent-Aragay, Jordi Badia-Ramentol, Alba Recort-Bascuas, Ana Méndez, Noemí Manero-Rupérez, Daniele Lo Re, Elisa I Rivas, Marc Guiu, Melissa Zwick, Mar Iglesias, Carolina Martinez-Ciarpaglini, Noelia Tarazona, Monica Varese, Xavier Hernando-Momblona, Adrià Cañellas-Socias, Mayra Orrillo, Marta Garrido, Nadia Saoudi, Elena Elez Fernandez, Pilar Navarro, Josep Tabernero, Roger R Gomis, Eduard Batlle, Jorge Pisonero, Andres Cervantes, Clara Montagut, Alexandre Calon
Long-term platinum-based drug accumulation in cancer-associated fibroblasts promotes colorectal cancer progression and resistance to therapy. Nature communications 14 (1) (2023)
Neus Martinez-Bosch, Noelia Vilariño, Francesc Alameda, Sergi Mojal, Montserrat Arumí-Uria, Cristina Carrato, Iban Aldecoa, Teresa Ribalta, Noemí Vidal, Beatriz Bellosillo, Silvia Menéndez, Sonia Del Barco, Oscar Gallego, Estela Pineda Losada, Raquel López-Martos, Ainhoa Hernández, Carlos Mesia, Anna Esteve-Codina, Nuria de la Iglesia, Carmen Balaña Quintero, Maria Martinez-García, Pilar Navarro
Gal-1 Expression Analysis in the GLIOCAT Multicenter Study: Role as a Prognostic Factor and an Immune-Suppressive Biomarker. Cells 12 (6) (2023)
Neus Martinez-Bosch, Noelia Vilariño, Francesc Alameda, Sergi Mojal, Montserrat Arumí-Uria, Cristina Carrato, Iban Aldecoa, Teresa Ribalta, Noemí Vidal, Beatriz Bellosillo, Silvia Menéndez, Sonia Del Barco, Oscar Gallego, Estela Pineda Losada, Raquel López-Martos, Ainhoa Hernández, Carlos Mesia, Anna Esteve-Codina, Nuria de la Iglesia, Carmen Balaña Quintero, Maria Martinez-García, Pilar Navarro
Gal-1 Expression Analysis in the GLIOCAT Multicenter Study: Role as a Prognostic Factor and an Immune-Suppressive Biomarker. Cells 12 (6) (2023)
Jenniffer Linares, Anna Sallent-Aragay, Jordi Badia-Ramentol, Alba Recort-Bascuas, Ana Méndez, Noemí Manero-Rupérez, Daniele Lo Re, Elisa I Rivas, Marc Guiu, Melissa Zwick, Mar Iglesias, Carolina Martinez-Ciarpaglini, Noelia Tarazona, Monica Varese, Xavier Hernando-Momblona, Adrià Cañellas-Socias, Mayra Orrillo, Marta Garrido, Nadia Saoudi, Elena Elez Fernandez, Pilar Navarro, Josep Tabernero, Roger R Gomis, Eduard Batlle, Jorge Pisonero, Andres Cervantes, Clara Montagut, Alexandre Calon
Long-term platinum-based drug accumulation in cancer-associated fibroblasts promotes colorectal cancer progression and resistance to therapy. Nature communications 14 (1) (2023)
Jenniffer Linares, Anna Sallent-Aragay, Jordi Badia-Ramentol, Alba Recort-Bascuas, Ana Méndez, Noemí Manero-Rupérez, Daniele Lo Re, Elisa I Rivas, Marc Guiu, Melissa Zwick, Mar Iglesias, Carolina Martinez-Ciarpaglini, Noelia Tarazona, Monica Varese, Xavier Hernando-Momblona, Adrià Cañellas-Socias, Mayra Orrillo, Marta Garrido, Nadia Saoudi, Elena Elez Fernandez, Pilar Navarro, Josep Tabernero, Roger R Gomis, Eduard Batlle, Jorge Pisonero, Andres Cervantes, Clara Montagut, Alexandre Calon
Long-term platinum-based drug accumulation in cancer-associated fibroblasts promotes colorectal cancer progression and resistance to therapy. Nature communications 14 (1) (2023)
Jenniffer Linares, Anna Sallent-Aragay, Jordi Badia-Ramentol, Alba Recort-Bascuas, Ana Méndez, Noemí Manero-Rupérez, Daniele Lo Re, Elisa I Rivas, Marc Guiu, Melissa Zwick, Mar Iglesias, Carolina Martinez-Ciarpaglini, Noelia Tarazona, Monica Varese, Xavier Hernando-Momblona, Adrià Cañellas-Socias, Mayra Orrillo, Marta Garrido, Nadia Saoudi, Elena Elez Fernandez, Pilar Navarro, Josep Tabernero, Roger R Gomis, Eduard Batlle, Jorge Pisonero, Andres Cervantes, Clara Montagut, Alexandre Calon
Long-term platinum-based drug accumulation in cancer-associated fibroblasts promotes colorectal cancer progression and resistance to therapy. Nature communications 14 (1) (2023)
Jenniffer Linares, Anna Sallent-Aragay, Jordi Badia-Ramentol, Alba Recort-Bascuas, Ana Méndez, Noemí Manero-Rupérez, Daniele Lo Re, Elisa I Rivas, Marc Guiu, Melissa Zwick, Mar Iglesias, Carolina Martinez-Ciarpaglini, Noelia Tarazona, Monica Varese, Xavier Hernando-Momblona, Adrià Cañellas-Socias, Mayra Orrillo, Marta Garrido, Nadia Saoudi, Elena Elez Fernandez, Pilar Navarro, Josep Tabernero, Roger R Gomis, Eduard Batlle, Jorge Pisonero, Andres Cervantes, Clara Montagut, Alexandre Calon
Long-term platinum-based drug accumulation in cancer-associated fibroblasts promotes colorectal cancer progression and resistance to therapy. Nature communications 14 (1) (2023)
Neus Martinez-Bosch, Noelia Vilariño, Francesc Alameda, Sergi Mojal, Montserrat Arumí-Uria, Cristina Carrato, Iban Aldecoa, Teresa Ribalta, Noemí Vidal, Beatriz Bellosillo, Silvia Menéndez, Sonia Del Barco, Oscar Gallego, Estela Pineda Losada, Raquel López-Martos, Ainhoa Hernández, Carlos Mesia, Anna Esteve-Codina, Nuria de la Iglesia, Carmen Balaña Quintero, Maria Martinez-García, Pilar Navarro
Gal-1 Expression Analysis in the GLIOCAT Multicenter Study: Role as a Prognostic Factor and an Immune-Suppressive Biomarker. Cells 12 (6) (2023)
Laura Miró, Júlia López, Pedro E Guerrero, Neus Martinez-Bosch, Noemí Manero-Rupérez, Mireia Moreno, Maria Rosa Ortiz, Esther Llop, Pilar Navarro, Rosa Peracaula
Sialyltransferase Inhibitor Ac 5 3F ax Neu5Ac Reverts the Malignant Phenotype of Pancreatic Cancer Cells, and Reduces Tumor Volume and Favors T-Cell Infiltrates in Mice. Cancers 14 (24) (2022)
Aleyda Benitez-Amaro, Neus Martinez-Bosch, Noemí Manero-Rupérez, Lene Claudi, Maria Teresa La Chica Lhoëst, Marta Soler, Lia Ros-Blanco, Pilar Navarro, Vicenta Llorente-Cortés
Peptides against Low Density Lipoprotein (LDL) Aggregation Inhibit Intracellular Cholesteryl Ester Loading and Proliferation of Pancreatic Tumor Cells. Cancers 14 (4) (2022)
Laura Miró, Júlia López, Pedro E Guerrero, Neus Martinez-Bosch, Noemí Manero-Rupérez, Mireia Moreno, Maria Rosa Ortiz, Esther Llop, Pilar Navarro, Rosa Peracaula
Sialyltransferase Inhibitor Ac 5 3F ax Neu5Ac Reverts the Malignant Phenotype of Pancreatic Cancer Cells, and Reduces Tumor Volume and Favors T-Cell Infiltrates in Mice. Cancers 14 (24) (2022)
Miguel Alejandro Galindo-Campos, Nura Lutfi, Sarah Bonnin, Carlos Manuel Martínez, Talía Velasco-Hernandez, Violeta García-Hernández, Juan Martin-Caballero, Coral Ampurdanés, Ramón Gimeno, Lluis Colomo, Gael Roue, Guillaume Guilbaud, Françoise Dantzer, Pilar Navarro, Matilde Murga, Oscar Fernandez-Capetillo, Anna Bigas, Pablo Menendez, Julian Sale, José Yélamos
Distinct roles for PARP-1 and PARP-2 in c-Myc-driven B-cell lymphoma in mice. Blood (2021)
Sara Picó, Alberto Parras, María Santos-Galindo, Julia Pose-Utrilla, Margarita Castro, Enrique Fraga, Ivó H Hernández, Ainara Elorza, Héctor Anta, Nan Wang, Laura Martí-Sánchez, Eulàlia Belloc, Paula Garcia-Esparcia, Juan José Garrido, Isidro Ferrer, Daniel Macías-García, Pablo Mir, Rafael Artuch, Belén Pérez, Félix Hernández, Pilar Navarro, José Luis López-Sendon Moreno, Teresa Iglesias, X William Yang, Raúl Méndez, José J Lucas
CPEB alteration and aberrant transcriptome-polyadenylation lead to a treatable SLC19A3 deficiency in Huntington's disease. Science translational medicine 13 (613) (2021)
Neus Martínez-Bosch, Alejo Rodriguez-Vida, Núria Juanpere, Josep Lloreta, Ana Rovira, Joan Albanell, Joaquim Bellmunt, Pilar Navarro
Galectins in prostate and bladder cancer: tumorigenic roles and clinical opportunities. Nature reviews. Urology 16 (7) (2020)
Pedro Enrique Guerrero, Laura Miró, Bin S Wong, Anna Massaguer, Neus Martínez-Bosch, Rafael de Llorens, Pilar Navarro, Konstantinos Konstantopoulos, Esther Llop, Rosa Peracaula
Knockdown of α2,3-Sialyltransferases Impairs Pancreatic Cancer Cell Migration, Invasion and E-selectin-Dependent Adhesion. International journal of molecular sciences 21 (17) (2020)
Pilar Navarro, Neus Martinez-Bosch, Ada G Blidner, Gabriel A Rabinovich
Impact of Galectins in Resistance to Anticancer Therapies. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (23) (2020)
Carlos A Orozco, Neus Martinez-Bosch, Pedro E Guerrero, Judith Vinaixa, Tomás Dalotto-Moreno, Mar Iglesias, Mireia Moreno, Magdolna Djurec, Françoise Poirier, Hans-Joachim Gabius, Martin E Fernandez-Zapico, Rosa F Hwang, Carmen Guerra, Gabriel A Rabinovich, Pilar Navarro
Targeting galectin-1 inhibits pancreatic cancer progression by modulating tumor-stroma crosstalk. Proceedings of the National Academy of Sciences of the United States of America 115 (16) (2018)
Eneko Villanueva, Pilar Navarro, Maria Rovira-Rigau, Annarita Sibilio, Raúl Méndez, Cristina Fillat
Translational reprogramming in tumour cells can generate oncoselectivity in viral therapies. Nature communications 8 (2017)

Pilar Navarro.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Pilar Navarro